Thomas Kisby

My group aims to harness the properties of nanomaterials/advanced materials and their interactions with cells and tissues for the development of safe and effective medicines, using advanced clinically-relevant disease models. Our mission is to further the progress of nanomedicine toward clinical translation, particularly in disease areas failed by conventional drugs and therapies such as neurooncology.

More information on the team and our work can be found here: https://nanotherapeuticslab.com

Tom obtained a BSc in Medical Sciences at the University of Leeds before completing his PhD in Regenerative Medicine at the University of Manchester within the Nanomedicine lab. His PhD work focussed on in vivo cell reprogramming approaches to tissue regeneration and the development of novel delivery vectors toward this. Tom then continued postdoctoral research with a shift in focus to cancer immunotherapy and neuro-oncology. Now, as a Research Fellow and group leader of the Nanotherapeutics lab within the Centre for Nanotechnology in Medicine, Tom is building a research programme around the application of both novel and repurposed nanomaterials for brain tumour therapy. 

Tom is a theme lead for the Nanotechnology for Brain Disease theme of the Geoffrey Jefferson Brain Research Centre (GJBRC) and has an affiliation with the Manchester Cancer Research Centre (MCRC) as part of their NanoOncology activity.

MSc Nanomedicine by Research

CDT NowNano